BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,310 | -37.8% | 750,053 | -38.1% | 0.05% | -26.1% |
| Q2 2023 | $8,536 | -16.2% | 1,212,547 | -0.7% | 0.07% | -17.9% |
| Q1 2023 | $10,189 | +3959.4% | 1,221,681 | +5493.3% | 0.08% | +2000.0% |
| Q4 2022 | $251 | -100.0% | 21,842 | -96.9% | 0.00% | -96.6% |
| Q3 2022 | $8,937,000 | +19.2% | 709,285 | +0.1% | 0.12% | +27.2% |
| Q2 2022 | $7,500,000 | +348.3% | 708,919 | +486.7% | 0.09% | +441.2% |
| Q4 2021 | $1,673,000 | +175.2% | 120,827 | +185.7% | 0.02% | +112.5% |
| Q3 2021 | $608,000 | -68.4% | 42,295 | -65.2% | 0.01% | -61.9% |
| Q2 2021 | $1,923,000 | +1024.6% | 121,603 | +238.1% | 0.02% | +425.0% |
| Q2 2020 | $171,000 | – | 35,969 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |